Trump Renews Tariff Threat on Indian Drugmakers, Dr. Reddy’s Slides
Trump renews tariff threat on Indian drugmakers, causing Dr. Reddy’s shares to drop 4.2% and raising risks for the Indian rupee and…
Trump renews tariff threat on Indian drugmakers, causing Dr. Reddy’s shares to drop 4.2% and raising risks for the Indian rupee and…
Rising crude oil costs and increased US rate-hike expectations are undercutting the Indian rupee's ability to benefit from strong dollar inflows, raising…
Indian refiners are rescuing Russia’s oil exporters by absorbing crude volumes, keeping global supply steady amid sanctions and deepening energy ties between…
InMobi's selection of JPMorgan and Jefferies as lead underwriters for its nearly $1 billion IPO signals strong demand for Indian tech listings,…
Foreign portfolio investors turn cautious on Indian sovereign debt, reducing allocations as global risk sentiment sours and domestic economic indicators flash warning…
SBI Funds raised $1 billion in India's biggest IPO this year, fueling expectations of a strong stock market debut and lifting sentiment…
India’s erratic monsoon season threatens crop yields and power grid stability, triggering inflationary risks and growth fears that rattle Indian equity markets…
SBI Funds Management paid record-low fees to bankers for India’s biggest 2026 IPO, underscoring fierce competition for high-profile listings in a booming…
India's private banks experience a surge in corporate lending despite rising bond yields, reflecting strong economic momentum and improving asset quality.
India's Udaan secures $160 million in fresh funding to fortify its balance sheet before a planned initial public offering, reflecting robust investor…
Vedanta Oil commits $5 billion to quintuple production, signaling a major expansion in its energy business that could lift Vedanta Limited's stock…
Indo-MIM's downsized $420 million IPO, set for July, points to cautious investor appetite and could set a tone for Indian equity capital…